MENLO PARK, Calif.--(BUSINESS WIRE)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools that improve the ability to perform minimally invasive orthopaedic procedures, today announced the issuance of a new patent adding to the company’s existing patent portfolio. The company’s innovative NovoStitch® suture passer is used in the repair of meniscal tears and other soft-tissue joint injuries.
Ceterix’s new patent further protects the company’s unique products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments. The NovoStitch suture passer allows the placement of a circumferential compression stitch in the knee meniscus, which is tightly surrounded by critical structures such as nerves, arteries and cartilage. This enables orthopaedic surgeons to treat complex injuries that have not been amenable to repair in the past. The NovoStitch technology can also be utilized in minimally invasive hip and shoulder procedures.
Help employers find you! Check out all the jobs and post your resume.
